Orasis Pharmaceuticals Closes $13 Million Series B Financing
HERZLIYA, Israel, June 5, 2018 – Orasis Pharmaceuticals LTD., a privately-held, clinical-stage pharmaceutical company focused on developing an innovative eye drop for the treatment of presbyopia symptoms, today announced the…